Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mohit Chawla

Clinical Cardiac Electrophysiology Cedar Rapids, IA Medical Doctor

NPI 1861477002 CMS profile 129983

202 10Th St Se, Suite 225, Cedar Rapids, IA 52403

Open in the dashboard

General payments

$100,857

563 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$120,477 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Mohit Chawla of Cedar Rapids, IA is reported in the CMS Open Payments database as having received $100,857 across 563 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $120,477 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 88th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,407 117
2024 General $19,966 98
2023 General $13,697 87
2022 General $10,081 106
2021 General $11,806 83
2020 General $4,431 50
2019 General $6,468 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohit Chawla
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Mohit Chawla were reported at $34,407. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Mohit Chawla Clinical Cardiac Electrophysiology median Middle half National median
2019 $6,468 $2,361 $585–$8,260 $163
2020 $4,431 $993 $247–$4,351 $114
2021 $11,806 $1,185 $326–$4,739 $132
2022 $10,081 $2,073 $554–$6,789 $149
2023 $13,697 $2,568 $759–$8,159 $160
2024 $19,966 $2,557 $703–$7,403 $164
2025 $34,407 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $51,331 140 payments
  2. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $29,707 54 payments
  3. Abbott Laboratories $10,593 240 payments
  4. Medtronic, Inc. $4,034 71 payments
  5. Medtronic Vascular, Inc. $2,491 25 payments
  6. Biosense Webster, Inc. $1,621 12 payments
  7. Philips Electronics North America Corporation $398 5 payments
  8. Impulse Dynamics (USA) Inc. $188 1 payment
  9. Edwards Lifesciences Corporation $115 5 payments
  10. Atricure, Inc. $108 1 payment
  11. Other $269 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $39,438 14 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $35,563 23 payments
  3. Food and Beverage $15,032 476 payments
  4. Travel and Lodging $10,824 50 payments
Products named General payments · program years 2019–2025
  1. LifeVest $29,707 54 payments
  2. General - Therapies General - Therapies_CRM $8,809 13 payments
  3. FARAPULSE $5,537 12 payments
  4. General Therapies Therapies $3,878 2 payments
  5. EnSite Precision Cardiac Mapping System $3,731 23 payments
  6. General - Therapies General - Therapies_EP $3,000 1 payment
  7. General - EP $2,188 2 payments
  8. GENERAL THERAPIES Pain Management $1,925 1 payment
  9. Carto 3 $1,420 9 payments
  10. Arctic Front $1,381 7 payments
  11. Other $15,838 396 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

1,142

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$225,157

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

42.8%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 223 $169,266
Xarelto Rivaroxaban Brand 46 $46,498
Metoprolol Succinate Generic 206 $1,905
Flecainide Acetate Generic 49 $1,720
Amiodarone Hcl Generic 100 $1,593
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 35 $734
Potassium Chloride Generic 13 $701
Clopidogrel Clopidogrel Bisulfate Brand 148 $671
Sotalol Sotalol Hcl Brand 25 $522
Digoxin Generic 44 $411

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$243,902

Medicare's payments for the services billed

Medicare patients

1,807

Average age 79

Services billed

5,860

792 women, 1,015 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 64%
Ischemic heart disease 54%
Heart failure 51%
Chronic kidney disease 43%
Arthritis 40%
Diabetes 37%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • PFIZER INC. $56
$56 223 —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

563 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record